Trial intelligence / Profile preview

Tamsulosin vs Solifenacin for Ureteral Stent Symptoms

NCT01880619Phase 4Completed

Sponsor
Mansoura University
Start
Jan 2013
Primary completion
May 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial in ureteral stent-related symptoms (USRS) comparing Placebo, Tamsulosin and Solifenacin (3 arms). Primary endpoint: Ureteral Stent Symptom Questionnaire Score at 1 year. Started Jan 2013; status: completed.

02

Drugs

tamsulosinsolifenacin
03

Conditions

ureteral stent-related symptoms (USRS)

Beyond the preview

Go deeper on NCT01880619.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01880619.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call